Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -HK$0.23 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion, an increase over its 2023 earnings that were of -HK$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year	Earnings	Change
2025 (TTM)	-HK$0.23 Billion	12.76%
2024	-HK$0.2 Billion	-15.25%
2023	-HK$0.24 Billion	11.62%
2022	-HK$0.21 Billion	30.84%
2021	-HK$0.17 Billion	15.58%
2020	-HK$0.14 Billion	3.41%
2019	-HK$0.14 Billion	51.16%
2018	-HK$88.79 Million	40.41%
2017	-HK$63.24 Million	27.54%
2016	-HK$49.58 Million	-47.49%
2015	-HK$94.42 Million	-17.25%
2014	-HK$0.12 Billion	35.91%
2013	-HK$83.96 Million	112.3%
2012	-HK$39.55 Million	46.53%
2011	-HK$26.99 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Johnson & Johnson JNJ	HK$252.18 B	-112,907.30%	🇺🇸 USA
LabCorp LH	HK$10.37 B	-4,742.38%	🇺🇸 USA
Quest Diagnostics DGX	HK$10.01 B	-4,581.51%	🇺🇸 USA
Enzo Biochem ENZB	-HK$61.04 Million	-72.70%	🇺🇸 USA
Translate Bio TBIO.defunct	HK$0.32 B	-245.14%	🇺🇸 USA
NeoGenomics NEO	-HK$0.86 Billion	280.29%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -HK$0.23 Billion